The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...
Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's stock has risen 4.6% this year against a decrease of 3.8% for the pharmaceuticals industry.